TMEM139
Transmembrane protein 139
Also known as: FLJ90586, TM139_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IV31
- Gene
- TMEM139
- Ensembl
- ENSG00000178826
- Chromosome
- 7
- Canonical length
- 216 aa
- Protein class
- Predicted membrane proteins, Transporters
- Subcellular location
- Plasma membrane,Focal adhesion sites
OverviewNCBI Gene
Predicted to be located in membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
216 residues, UniProt reviewed canonical sequence.
>Q8IV31|TMEM139
1 MVPMHLLGRL EKPLLLLCCA SFLLGLALLG IKTDITPVAY FFLTLGGFFL FAYLLVRFLE
61 WGLRSQLQSM QTESPGPSGN ARDNEAFEVP VYEEAVVGLE SQCRPQELDQ PPPYSTVVIP
121 PAPEEEQPSH PEGSRRAKLE QRRMASEGSM AQEGSPGRAP INLRLRGPRA VSTAPDLQSL
181 AAVPTLEPLT PPPAYDVCFG HPDDDSVFYE DNWAPPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TMEM139 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.61
- Highest tissue expression
- 32 nTPM
Expression across tissuesHPA
Tissue
- duodenum: 32 nTPM
- kidney: 30 nTPM
- small intestine: 18 nTPM
- spinal cord: 15 nTPM
- liver: 9 nTPM
- cervix: 8.4 nTPM
Single-cell type
- enterocytes: 81 nCPM
- endometrial secretory cells: 43 nCPM
- alveolar cells type 1: 41 nCPM
- colonocytes: 41 nCPM
- cytotrophoblasts: 37 nCPM
- breast myoepithelial cells: 30 nCPM
Immune cell
- intermediate monocyte: 0.8 nTPM
- non-classical monocyte: 0.8 nTPM
- T-reg: 0.6 nTPM
- memory CD4 T-cell: 0.3 nTPM
- naive CD4 T-cell: 0.3 nTPM
- eosinophil: 0.2 nTPM
Brain region
- white matter: 30 nTPM
- medulla oblongata: 25 nTPM
- pons: 19 nTPM
- midbrain: 17 nTPM
- cerebellum: 17 nTPM
- basal ganglia: 16 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.35
- gnomAD pLI
- 0.01
- gnomAD missense Z
- -0.21
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Transmembrane protein 139
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TMEM139 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TMEM139 as an antibody target. Whether an autoantibody or antibody against TMEM139 could matter depends on whether native TMEM139 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TMEM139 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TMEM139 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...